Product Name
IRF9 Recombinant Rabbit Monoclonal Antibody [PSH07-87] - BSA and Azide free
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human IRF9 aa 1-393.
Validated Applications
WB, IHC-P, IF-Cell, FC, IP
Target Molecular Weight
Predicted band size: 44 kDa
Positive Control
HeLa cell lysate, HeLa treated with 10ng/mL IFN-α1 for 16 hours cell lysate, Daudi cell lysate, Daudi treated with 10ng/mL IFN-α1 for 16 hours cell lysate, Jurkat cell lysate, Jurkat treated with 100nM IFN-α1 for 24 hours cell lysate, THP-1 cell lysate, C2C12 cell lysate, PC-12 cell lysate, Mouse spleen tissue lysate, Mouse lung tissue lysate, Rat spleen tissue lysate, Rat lung tissue lysate, HeLa cells treated with 10ng/mL IFN-α1 for 16 hours, mouse spleen tissue, rat spleen tissue.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
Interferon regulatory factor 9 is a protein that in humans is encoded by the IRF9 gene, previously known as ISGF3G. Transcription factor that plays an essential role in anti-viral immunity. It mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
Background References
1. Lan C et al. Suppression of IRF9 Promotes Osteoclast Differentiation by Decreased Ferroptosis via STAT3 Activation. Inflammation. 2024 Feb
2. Zhao Q et al. An MRTF-A-ZEB1-IRF9 axis contributes to fibroblast-myofibroblast transition and renal fibrosis. Exp Mol Med. 2023 May
Synonyms
IFN alpha responsive transcription factor subunit antibody
IFN-alpha-responsive transcription factor subunit antibody
Interferon regulatory factor 9 antibody
interferon stimulated transcription factor 3 antibody
Interferon-stimulated gene factor 3 gamma antibody
interferon-stimulated transcription factor 3, gamma 48kDa antibody
IRF 9 antibody
IRF-9 antibody
Irf9 antibody
IRF9_HUMAN antibody
Expand
IFN alpha responsive transcription factor subunit antibody
IFN-alpha-responsive transcription factor subunit antibody
Interferon regulatory factor 9 antibody
interferon stimulated transcription factor 3 antibody
Interferon-stimulated gene factor 3 gamma antibody
interferon-stimulated transcription factor 3, gamma 48kDa antibody
IRF 9 antibody
IRF-9 antibody
Irf9 antibody
IRF9_HUMAN antibody
ISGF 3 gamma antibody
ISGF-3 gamma antibody
ISGF3 antibody
ISGF3 p48 subunit antibody
ISGF3G antibody
OTTHUMP00000164692 antibody
OTTHUMP00000164693 antibody
p48 antibody
Transcriptional regulator ISGF3 subunit gamma antibody
Collapse
-
☑ Cell treatment (CT)
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Western blot analysis of IRF9 on different lysates with Rabbit anti-IRF9 antibody (HA722916) at 1/2,000 dilution.
Lane 1: HeLa cell lysate (20 µg/Lane)
Lane 2: HeLa treated with 10ng/mL IFN-α1 for 16 hours cell lysate (20 µg/Lane)
Lane 3: Daudi cell lysate (20 µg/Lane)
Lane 4: Daudi treated with 10ng/mL IFN-α1 for 16 hours cell lysate (20 µg/Lane)
Lane 5: Jurkat cell lysate (20 µg/Lane)
Lane 6: Jurkat treated with 100nM IFN-α1 for 24 hours cell lysate (20 µg/Lane)
Lane 7: THP-1 cell lysate (20 µg/Lane)
Lane 8: C2C12 cell lysate (20 µg/Lane)
Lane 9: PC-12 cell lysate (20 µg/Lane)
Lane 10: Mouse spleen tissue lysate (40 µg/Lane)
Lane 11: Mouse lung tissue lysate (40 µg/Lane)
Lane 12: Rat spleen tissue lysate (40 µg/Lane)
Lane 13: Rat lung tissue lysate (40 µg/Lane)
Predicted band size: 44 kDa
Observed band size: 48 kDa
Exposure time: 25 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA722916) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Western blot analysis of IRF9 on different lysates with Rabbit anti-IRF9 antibody (HA722916) at 1/2,000 dilution.
Lane 1: Human IRF9 recombinant protein, 30ng/Lane
Lane 2: Human IRF8 recombinant protein, 30ng/Lane
Exposure time: 2 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA722916) at 1/2,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Cell treatment (CT)
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of HeLa cells treated with 10ng/mL IFN-α1 for 16 hours labeling IRF9 with Rabbit anti-IRF9 antibody (HA722916) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-IRF9 antibody (HA722916) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded mouse spleen tissue with Rabbit anti-IRF9 antibody (HA722916) at 1/50 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA722916) at 1/50 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded rat spleen tissue with Rabbit anti-IRF9 antibody (HA722916) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA722916) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
☑ Cell treatment (CT)
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of HeLa cells treated with 10ng/mL IFN-α1 for 16 hours labeling IRF9.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA722916, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
-
This data was developed using HA722916, the same antibody clone in a different buffer formulation.
IRF9 was immunoprecipitated from 0.2 mg HeLa cell lysate with HA722916 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using HA722916 at 1/2,000 dilution. Anti-Rabbit IgG for IP, AlpSdAbs® VHH(HRP) (025-100-005) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: HeLa cell lysate (input)
Lane 2: HA722916 IP in HeLa cell lysate
Lane 3: Rabbit IgG instead of HA722916 in HeLa cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 1 minute; ECL: K1802
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"